1-4 of 4
Lam G. Vuong, PhD
Close
Sort by
Journal Articles

Grouping of Genetic Risk By the European Leukemia Net Classification Predicts Overall Survival and Relapse Incidence in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Philipp G. Hemmati, MD, Theis Terwey, MD, Il-Kang Na, MD, Christian Jehn, MD, Lam G. Vuong, PhD, Philipp le Coutre, MD, Bernd Dörken, MD, Renate Arnold, MD
Journal: Blood
Blood (2015) 126 (23): 2012.
https://doi.org/10.1182/blood.V126.23.2012.2012
Published: 2015
Journal Articles

Achieving Early Remission By Induction Therapy Predicts a Favorable Outcome in Patients with Acute Myeloid Leukemia and an Intermediate Risk Karyotype Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Il-Kang Na, MD, Philipp le Coutre, MD, Christian F. Jehn, MD, Lam G. Vuong, PhD, Bernd Dörken, MD, Renate Arnold, MD
Journal: Blood
Blood (2014) 124 (21): 2569.
https://doi.org/10.1182/blood.V124.21.2569.2569
Published: 2014
Journal Articles

Allogeneic Stem Cell Transplantation For Cytogenetically Normal Acute Myeloid Leukemia: Impact Of FLT3 and NPM1 Mutational Status

Philipp Hemmati, MD, Theis H. Terwey, MD, Lam G. Vuong, PhD, Philipp D le Coutre, MD, Bernd Dörken, MD, Renate Arnold, MD
Journal: Blood
Blood (2013) 122 (21): 2104.
https://doi.org/10.1182/blood.V122.21.2104.2104
Published: 2013
Journal Articles

Pre-Transplant Risk-Assessment for Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplants.

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Philipp le Coutre, MD, Gero Massenkeil, MD, Lam G Vuong, PhD, Christian Jakob, MD, Arturo Vega, MD, Bernd Dörken, MD, Renate Arnold, MD
Journal: Blood
Blood (2009) 114 (22): 2302.
https://doi.org/10.1182/blood.V114.22.2302.2302
Published: 2009